COPD: Page 19

Live bacteria could help improve lung function in COPD patients
Study examines the use of Lactobacilli bacteria as potential therapy.
August 28, 2024
A. Schematic of the spray drying process used to dry Lactobacillus strains into small, flowable powder particles. B. Scanning electron microscope (SEM) images of three formulations of powder particles after drying. Images at 25,000, 50,000, and 100,000x magnification (left to right) were taken from one sample each.
Increased wildfire activity leads to problems for COPD, asthma patients
Population health-based action plan could mitigate effects of poor air quality.
August 22, 2024
Image of lungs with wildfire burning on the right side.
Inhaler misuse can increase COPD exacerbations
Approximately 66% of patients misuse inhalers, signaling additional education is needed.
August 22, 2024
Older man using an inhaler with female medical professional in the backround.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Genetics of COPD play big role in lung function of young people
Researchers find that genes could contribute along with air pollution and smoking.
August 15, 2024
Box plot of variance in FEV1/FVC explained by the PRS for airflow limitation across the lifespan.
American Thoracic Society calls for research into multiple key areas
The organization said more research is needed to improve outcomes in patients with COPD and cardiovascular disease.
August 15, 2024
Female researcher in a lab setting working on a touch screen monitor
FDA grants Tezspire breakthrough therapy designation for COPD
The announcement was based on encouraging results from earlier trials.
August 9, 2024
Scientist in white lab coat wearing blue gloves examining a scientific sample container
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Pulmonary fibrosis insight
COPD not associated with increased mortality in COVID patients
Researchers studied patients diagnosed with the Omicron variant of COVID-19.
August 1, 2024
Abstract image of COVID-19 virus cell.
ICER issues access and affordability alert for ensifentrine
The high cost of the drug could lead to increased costs for other services within the health care system.
July 24, 2024
Stethoscope in the shape of a dollar sign.
Adults no more susceptible to common infections than prior to COVID pandemic
The prevalence of asthma, COPD, did not increase in 2023 compared to 2019.
July 24, 2024
Graph showing a decline in respiratory and infectious illnesses in adults prior to and after the COVID-19 pandemic.
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Pulmonary fibrosis insight
European patent issued for brilaroxazine
Patent covers the usage for treatment of pulmonary hypertension in COPD patients.
July 15, 2024
Home caregiver measuring blood pressure of a female patient at home
European Union approves Dupixent
Inaugural approval of the new treatment for uncontrolled COPD.
July 11, 2024
Map of the European Union.
Patients with COPD face psychological challenges
Canadian study finds that social and clinical support may be key to treatment.
July 11, 2024
Woman with a comforting hand on her shoulder.
Previous Page
Page 19 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial